Biogen on the hunt for acquisition after $1B in cuts, 15% workforce reduction

Biogen's CEO says the company's late-stage pipeline is in good shape, but the drugmaker is still hunting for deals to build ...

Oracle Is On A Roll But Debt Burden Fears Seem Valid

Michael Burry bets against Oracle as debt nears $100B, FCF turns -$13B and a $6.6B liquidity gap looms—see ORCL stock's risks and cloud upside here.